Advertisement

Tumor Biology

, Volume 33, Issue 6, pp 2379–2383 | Cite as

The effect of lysyl oxidase polymorphism on susceptibility and prognosis of nonsmall cell lung cancer

  • Weiwei Shi
  • Bo Yang
  • Xiaoyan Li
  • Shengjie Sun
  • Lijie Wang
  • Shunchang Jiao
Research Article

Abstract

Lysyl oxidase (LOX) is a copper-dependent amine oxidase that plays important roles in development and homeostasis of the lungs. The aim of this study was to investigate whether polymorphisms in the LOX gene were associated with susceptibility to nonsmall cell lung cancer (NSCLC). We sequenced the promoter region of LOX gene and tested the previously reported polymorphism 473 G/A in the Han Chinese population. A novel polymorphism, −22 G/C, was identified in the promoter region of LOX. However, it did not show any correlation with NSCLC. Frequencies of the 473AA genotype and 473A allele were significantly higher in the NSCLC cases than in control group (p = 0.004 and p = 0.006, respectively). Further, our results showed that survival time of NSCLC patients with 473AA genotype was significantly shorter compared to the cases carrying 473 G allele (20.0 months vs. 28.0 months, p = 0.011). These data indicate that LOX 473 G/A polymorphism is associated with increased risk of NSCLC and can be a prognostic predictor for this disease.

Keywords

Lysyl oxidase Polymorphism Non-small cell lung cancer 

References

  1. 1.
    Lawrence RE, Salgia R. MET molecular mechanisms and therapies in lung cancer. Cell Adh Migr. 2010;4:146–52.PubMedCrossRefGoogle Scholar
  2. 2.
    Li X, Shi W, Yu G, Lin L, Yang B, Li J, et al. Interleukin-4–590T/C polymorphism influences the susceptibility to nonsmall cell lung cancer. DNA Cell Biol. 2012;31:797–800.PubMedCrossRefGoogle Scholar
  3. 3.
    Song B, Liu Y, Liu J, Song X, Wang Z, Wang M, et al. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis. Respiration. 2011;82:439–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. 2006;63:2304–16.PubMedCrossRefGoogle Scholar
  5. 5.
    Atsawasuwan P, Mochida Y, Katafuchi M, Kaku M, Fong KS, Csiszar K, et al. Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity. J Biol Chem. 2008;283:34229–40.PubMedCrossRefGoogle Scholar
  6. 6.
    Moore RH, Spies MA, Culpepper MB, Murakawa T, Hirota S, Okajima T, et al. Trapping of a dopaquinone intermediate in the TPQ cofactor biogenesis in a copper-containing amine oxidase from Arthrobacter globiformis. J Am Chem Soc. 2007;129:11524–34.PubMedCrossRefGoogle Scholar
  7. 7.
    Kothapalli CR, Ramamurthi A. Lysyl oxidase enhances elastin synthesis and matrix formation by vascular smooth muscle cells. J Tissue Eng Regen Med. 2009;3:655–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Lee JE, Kim Y. A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity. J Biol Chem. 2006;281:37282–90.PubMedCrossRefGoogle Scholar
  9. 9.
    Payne SL, Hendrix MJC, Kirschmann DA. Paradoxical roles for lysyl oxidase in cancer—a prospect. J Cell Biochem. 2007;101:1338–54.PubMedCrossRefGoogle Scholar
  10. 10.
    Montel V, Huang TY, Mose E, Pestonjamasp K, Tarin D. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Pathol. 2005;166:1565–79.PubMedCrossRefGoogle Scholar
  11. 11.
    Tsuchiya MI, Okuda H, Takaki Y, Baba M, Hirai SI, Ohno S, et al. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones. Oncol Rep. 2005;13:1033–41.PubMedGoogle Scholar
  12. 12.
    Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, et al. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene. 2001;20:2225–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Rost T, Pyritz V, Rathcke IO, Gorogh T, Dunne AA, Werner JA. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer Res. 2003;23:1565–73.PubMedGoogle Scholar
  14. 14.
    Uzel MI, Shih SD, Gross H, Kessler E, Gerstenfeld LC, Trackman PC. Molecular events that contribute to lysyl oxidase enzyme activity and insoluble collagen accumulation in osteosarcoma cell clones. J Bone Miner Res. 2000;15:1189–97.PubMedCrossRefGoogle Scholar
  15. 15.
    Wilgus ML, Borczuk AC, Stoopler M, Ginsburg M, Gorenstein L, Sonett JR, et al. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer. 2011;117:2186–91.PubMedCrossRefGoogle Scholar
  16. 16.
    Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, Trackman PC, et al. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res. 2009;69:6685–93.PubMedCrossRefGoogle Scholar
  17. 17.
    Yoon JH, Park JK, Kang YH, Park YK, Nam SW, Lee JY, et al. Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population. APMIS. 2011;119:762–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, et al. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer. 2006;106:1250–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2007;2:694–705.PubMedCrossRefGoogle Scholar
  20. 20.
    Gao S, Zhao Y, Kong L, Toselli P, Chou IN, Stone P, et al. Cloning and characterization of the rat lysyl oxidase gene promoter: identification of core promoter elements and functional nuclear factor I-binding sites. J Biol Chem. 2007;282:25322–37.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2012

Authors and Affiliations

  • Weiwei Shi
    • 1
  • Bo Yang
    • 1
  • Xiaoyan Li
    • 2
  • Shengjie Sun
    • 1
  • Lijie Wang
    • 1
  • Shunchang Jiao
    • 1
  1. 1.Department of OncologyPLA General HospitalBeijingChina
  2. 2.Department of Lung CancerAffiliated Hospital of Academy of Military Medical Sciences, PLABeijingChina

Personalised recommendations